Search

The author presents comments on a study of droplet-based microfluidic system for individual Caenorhabditis elegans (C. elegans) assay. He states that the well-characterized genome of the nematode is an ideal system to examine the silencing of genes. He also notes that the researchers have developed the system to encapsulate C. elegans for assaying response to a neurotoxin. He adds that the research adds to the growth of microfluidic systems to support studies on protein structure, particle synthesis and in vitro assays.

Far more publications are available for osteoarthritis of the knee than of the hip. Recognizing this research gap, the Arthritis Foundation (AF), in partnership with the Hospital for Special Surgery (HSS), convened an in-person meeting of thought leaders to review the state of the science of and clinical approaches to hip osteoarthritis. This article summarizes the recommendations gleaned from presentations given in the "late-stage osteoarthritis" session of the 2023 Hip Osteoarthritis Clinical Studies Conference, which took place on February 17 and 18, 2023, in New York City. It covers conservative treatment, decision-making in end-stage hip osteoarthritis, advancements in robotics, and the role of phenotyping in precision rehabilitation post-total hip arthroplasty (THA)., Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.B., MD, reports relationships with Smith+Nephew, Lima Corporate, and Globus Medical. B.C., MD, reports relationships with Smith+Nephew, Orthodevelopment, HSS Journal, and Journal of Arthroplasty. M.B., PhD, reports relationships with the NIH (clinical trial grant # R01HD084124). M.P.B., MD, reports relationships with Smith+Nephew, Hip Society, and American Austrian Foundation. The other authors declare no potential conflicts of interest., (© The Author(s) 2023.)

Far more publications are available for osteoarthritis of the knee than of the hip. Recognizing this research gap, the Arthritis Foundation, in partnership with the Hospital for Special Surgery, convened an in-person meeting of thought leaders to review the state of the science of and clinical approaches to hip osteoarthritis. This article summarizes the recommendations and clinical research gaps gleaned from 5 presentations given in the "how hip osteoarthritis begins" session of the 2023 Hip Osteoarthritis Clinical Studies Conference, which took place on February 17 and 18, 2023, in New York City., Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Young-jo Kim, MD, PhD, reports a relationship with Cytex. Nancy E. Lane, MD, reports a relationship with Biosplice. Michael B. Millis, MD, reports relationships with the Peabody Foundation, Elsevier, and University of Minnesota. Amanda E. Nelson, MD, reports relationships with the NIH/NIAMS, CDC (National Institutes of Health / National Institute of Arthritis and Musculoskeletal and Skin Diseases K23AR061406, L30AR056604, P60AR064166, and P30AR072580; Centers for Disease Control and Prevention U01DP006266), University of Alabama, and Osteoarthritis Research Society International. Mathias P. Bostrom, MD, reports a relationship with Smith + Nephew. The other authors declared no potential conflicts of interest., (© The Author(s) 2023.)

Far more publications are available for osteoarthritis of the knee than of the hip. Recognizing this research gap, the Arthritis Foundation (AF), in partnership with the Hospital for Special Surgery (HSS), convened an in-person meeting of thought leaders to review the state of the science of and clinical approaches to hip osteoarthritis. This article summarizes the recommendations gleaned from 5 presentations given on hip-related rehabilitation at the 2023 Hip Osteoarthritis Clinical Studies Conference, which took place on February 17 and 18, 2023, in New York City., Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Kate N. Jochimsen, PhD, ATC; Jason S. Kim, PhD; Prakash Jayabalan MD, PhD; Cara L. Lewis, PT, PhD; Heidi Prather, DO; and Cecelia Lawrence, PT, declare no potential conflicts of interest. Mathias P. Bostrom, MD, reports a relationship with Smith+Nephew., (© The Author(s) 2023.)

Far more publications are available for osteoarthritis of the knee than of the hip. Recognizing this research gap, the Arthritis Foundation (AF), in partnership with the Hospital for Special Surgery (HSS), convened an in-person meeting of thought leaders to review the state of the science of and clinical approaches to hip osteoarthritis. This article summarizes the recommendations gleaned from 5 presentations given in the "early hip osteoarthritis" session of the 2023 Hip Osteoarthritis Clinical Studies Conference, which took place on February 17 and 18, 2023, in New York City. It also summarizes the workgroup recommendations from a small-group discussion on clinical research gaps., Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: CP-G reports relationships with Arvis and ZedView. RL received a patent, #US 10,185,010. MPB reports a relationship with Smith and Nephew. The other authors declare no potential conflicts of interest., (© The Author(s) 2023.)